Skip to main content

Critical Illness Insurance Market is Growing Dynamically at a Healthy CAGR of 15.35% During Forecast to 2025

Critical Illness Insurance Market: Information by Application (Cancer, Heart Attack, Stroke, and others) and by Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) - Forecast till 2025
Market Highlights:
Critical illness insurance is a type of insurance, where the insurer comes in a contract to make a lump sum cash payment if the policyholder is diagnosed with some specific critical disease as a part of the insurance policy. Critical illness insurance is also known as critical insurance cover or dread disease policy.

The global Critical Illness Insurance Market Trends is expected to register a CAGR of 15.35% during the forecast period, with a market value of USD 67,960.81 million by 2025.

Get a Free Sample @ https://www.marketresearchfuture.com/reports/critical-illness-insurance-market-8734
The increasing cases of critical illness and increasing out of pocket expenditure for the insured and uninsured population are expected to drive the growth of the critical illness insurance market. However, lack of awareness about critical illness insurance is expected to hamper the market growth during the forecast period.

Competitive Landscape:                                                                   
  • China Life Insurance Company
  • Allianz
  • Ping An Insurance
  • Aviva
  • Prudential
  • Aegon
  • AXA
  • Sun Life Financial
  • Aflac Incorporated
  • Huaxia Life Insurance Co
  • AIG
  • MetLife Services and Solutions
  • Zurich

Segment Analysis:
  • The global critical illness insurance market has been divided based on application and region.
  • The market, based on application, has been bifurcated into cancer, heart attack, stroke, and others. In 2018, the cancer segment held the largest market share owing to the rise in the number of cancer cases. For instance, an estimated 1,735,350 new cases of cancer were diagnosed in the US and 609,640 people died from the disease in 2018.

Regional Analysis:
The global critical illness insurance market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is likely to hold the largest share of the global critical illness insurance market during the assessment period. The rising prevalence of chronic diseases, including cancer and rising medical expenses, are expected to support the dominance of the Americas during the forecast period. Moreover, in the US, there has been a significant rise in the number of insured populations in the past few years. For instance, the percentage of the uninsured population in the US was about 14% in 2008, and this came down to nearly 8.5% in 2018.
Furthermore, about 99.1% of the population aged 65 and above were insured in 2018 in the US. The Europe market established substantial growth in the market due to the high prevalence of critical illnesses such as cancer, heart attack, and stroke, among others in this region. Asia-Pacific is estimated to be the fastest-growing region in the global market due to the increasing geriatric population, presence of expensive health facilities and an increase in the demand for health insurance policies in high populous countries such as India and China. The critical illness insurance market in the Middle East & Africa is expected to witness gradual growth due to the increasing life expectancy, enlarging middle class, and population growth. Moreover, the launch of the life insurance reform project in 2016 in the United Arab Emirates would support the market growth in this region.
Related Reports:
https://www.marketresearchfuture.com/reports/health-insurance-market-8227

Labels:

Comments

Post a Comment

Popular posts from this blog

Covid 19 Analysis on Respiratory Therapeutic Devices Market Analysis and Forecast to 2023

Market Overview: The Global Respiratory Therapeutic Devices Market is predicted to scale to new heights and expand at a CAGR of 10.8% over the forecast period of 2017-2023, asserts Market Research Future (MRFR) in an in-depth study.                   The growth of the Global Covid 19 Analysis on Respiratory Therapeutic Devices Market Analysis   is primarily led by the recent surge in the incidence of chronic respiratory diseases such as asthma, COPD, and sleep disorder breathing. As per the estimates of the World Health Organization (WHO), approximately 235 Mn people suffered from asthma in 2017 across the globe. The growing burden of chronic respiratory diseases (CRDs) induces strong demand for respiratory therapeutic devices within the market. Moreover, with the increase in the global aging population, there is a greater need for respiratory therapeutic devices.     ...
Post a Comment
Read more

Antibody Drug Conjugate Market is Presumed to Grow at a Reliable CAGR of 19% During Forecast to 2023

Antibody Drug Conjugate Market Analysis: Various factors are adding to the global antibody drug conjugate market share. These factors, as per the new MRFR report, include advances in medical technology, rising cases of cancer, growing obese population, and increasing aging population. Additional factors adding market growth include increasing collaborations between biotechnology companies, biopharmaceuticals, and research institutes, rising R&D on oncology diseases, increasing research on advanced drug discoveries, rising number of research on antibody therapies, and preclinical research. The global Antibody Drug Conjugate Market Share is likely to grow at a 19% CAGR between 2017- 2023 , reveals the new Market Research Future (MRFR) report. Antibody drug conjugates are new-age therapeutic agents that have three parts- a chemical linker to attach cytotoxic agents to antibodies, cytotoxic agents for killing target cancer cells, and specific antibodies for binding. Lymphoma, mult...
Post a Comment
Read more

Desalting and Buffer Exchange Market is Growing at a Healthy CAGR of 10.5% During Forecast to 2023

Market Highlights: The Global Desalting and Buffer Exchange Market is anticipated to have held a market value of USD 615.20 million in the year 2017 and is expected to grow at a CAGR of 10.5% during the forecast period. Desalting and buffer exchange play a key role in biotechnological companies. Buffer exchange is used to place a protein solution into a more suitable buffer before applications such as electrophoresis, ion exchange, affinity chromatography among others. Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/6633 Buffer exchange is the term used when one set of buffer salts in a sample is exchanged by another more appropriate buffer set. The rising demand for monoclonal antibodies, growing research and development expenditure by the biopharmaceutical companies, and rising focus on proteomic and genomic research is anticipated to boost the growth of the market over the forecast period. However, the dearth of skilled professionals is excepted to ...
Post a Comment
Read more